載入...

CAUTION ADVISED USING COMBINATION KETOCONAZOLE AND PD-1 INHIBITORS

OBJECTIVE: Immune checkpoint inhibitors are approved to treat multiple cancers. We report life-threatening hepatic failure in 2 consecutive patients with Cushing syndrome that were treated with ketoconazole (KTZ) in combination with 2 different programmed cell death protein 1 (PD-1) inhibitors, Nivo...

全面介紹

Na minha lista:
書目詳細資料
發表在:AACE Clin Case Rep
Main Authors: Yang, Yingying, Hecht, Joel R., Liu, Sandy Ting, Cohen, Melissa J., Hart, Steven D., Wang, Hanlin L., Heaney, Anthony P.
格式: Artigo
語言:Inglês
出版: American Association of Clinical Endocrinologists 2020
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7511096/
https://ncbi.nlm.nih.gov/pubmed/32984529
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4158/ACCR-2020-0100
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!